Shareholding Pattern For June 30, 2015
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.16-07-2015
16-07-2015
Clarification
With reference to the Increase in Volume, Jubilant Life Sciences Ltd has Clarified to BSE as under:"We do not have any information under Clause 36 of the Listing Agreement or otherwise to disclose / share with the stock exchanges. We have, in the past, been disclosing all relevant information to the stock exchanges at appropriate time. We take this opportunity to assure that we shall continue disclosing all price sensitive information...10-07-2015
Clarification sought from Jubilant Life Sciences Ltd
The Exchange has sought clarification from Jubilant Life Sciences Ltd on July 10, 2015.The reply is awaited.10-07-2015
Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated June 23, 2015 titled "Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets".23-06-2015
Jubilant Life Sciences announces price increase of 10% for Niacinamide
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated June 16, 2015 titled "Jubilant Life Sciences announces price increase of 10% for Niacinamide".16-06-2015
Jubilants Spokane facility successfully concludes inspection status
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated June 12, 2015 titled "Jubilants Spokane facility successfully concludes inspection status".12-06-2015
Code of Conduct of Fair Disclosure
Jubilant Life Sciences Ltd has informed BSE that the following :1. Jubilant Life Sciences Limited (the "Company") has formulated and published on its website, the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. A Copy of the Code is enclosed; and2. The Company has formulated a Code of Conduct for Prevention of Insider Trading.15-05-2015
Clause 20
Jubilant Life Sciences Ltd has submitted to BSE a copy of Clause 20 of the Listing Agreement for the Financial Year ended March 31, 2015.12-05-2015
Board recommends Dividend
Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2015, has recommended a dividend of Rs.3/- (Rupees Three) per equity share of Re.1/- each for the year ended March 31, 2015. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before September 30,2015.12-05-2015
Announces Q4 & FY15 results, Results Press Release, Presentation & Auditors' Report for the period ended March 31, 2015
Jubilant Life Sciences Ltd has announced the following results for the quarter & year ended March 31, 2015:The Audited results for the Quarter ended March 31, 2015The Company posted a net loss after taxes of Rs. (2068.90) million for the Quarter ended March 31, 2015 where as the same was at Rs. 207.60 million for the Quarter ended March 31, 2014. Total Income is Rs. 7468.60 million for the Quarter ended March 31, 2015 where as the...12-05-2015